Company Developments

  • July 2006 Opal increases infrastructure and moves its commercial premises to SW England.
  • March 2006 Opal achieves ISO 9001/2000.
  • October 2005 Opal develop collaboration with an analytical company for development of its first antibiotic for the worldwide market.
  • February 2005 Opal secures its Import license and starts early importation of its own generics.
  • September 2004 Opal secures a DTI grant for “An innovative idea” to explore new technologies for small molecules.
  • August 2004 Opal achieves its first MA for an antibiotic tablet for use  in hospital and retail markets.
  • June 2004 Opal Healthcare Limited secures phase III funding.
  • March 2004 Opal is approved as a supplier for the UK NHS.
  • September 2003 Opal Healthcare Limited secures phase II funding
  • March 2003 Incorporation of Oncogen B.V.
  • January 2003 Opal Healthcare starts trading.
  • December 2002 Opal Healthcare Limited secures phase I funding.